- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 652817, 5 pages
Sex Differences in Constitutive Autophagy
LAGENBIO-I3A, Veterinary School, University of Zaragoza, Miguel Servet 177, 50013 Zaragoza, Spain
Received 19 November 2013; Revised 13 January 2014; Accepted 27 January 2014; Published 27 February 2014
Academic Editor: Patrick G. Kehoe
Copyright © 2014 Sara Oliván et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Sex bias has been described nowadays in biomedical research on animal models, although sexual dimorphism has been confirmed widely under pathological and physiological conditions. The main objective of our work was to study the sex differences in constitutive autophagy in spinal cord and skeletal muscle tissue from wild type mice. To examine the influence of sex on autophagy, mRNA and proteins were extracted from male and female mice tissues. The expressions of microtubule-associated protein 1 light chain 3 (LC3) and sequestosome 1 (p62), markers to monitor autophagy, were analyzed at 40, 60, 90, and 120 days of age. We found significant sex differences in the expression of LC3 and p62 in both tissues at these ages. The results indicated that sex and tissue specific differences exist in constitutive autophagy. These data underlined the need to include both sexes in the experimental groups to minimize any sex bias.
In biomedical research, single-sex studies (generally males) still predominate. Moreover, a high number of studies either fail to specify the sex used or the two sexes are not analyzed separately. In neuroscience or pharmacology, for example, a higher number of studies are conducted in males (5.5 : 1 or 5 : 1) albeit gender differences have been previously described . However, an increasing number of investigations about the influence of gender in human disorders (cancer, neurodegenerative, or cardiovascular diseases) or fundamental biological pathways, such as autophagy, are currently being carried out.
Autophagy is a dynamic system for degrading misfolded and/or damaged proteins and, therefore, for maintaining the cellular homeostasis . During this process, small portions of cytoplasm are sequestered by a double membrane bound vesicles called autophagosomes and consequently degraded when they fuse with lysosomes to form an autolysosome. Cellular autophagic activity is usually low under normal physiological conditions (constitutive autophagy) but can be markedly upregulated by numerous stimuli (starvation, hypoxia, or infections) or suppressed as documented in the case of neurodegenerative disorders and cancer . Specifically in neural cells, the role of constitutive autophagy has been studied and the results indicate that it is essential to prevent certain neurodegenerative diseases [4, 5].
Sex-dependent differences in the activation of the autophagic cytoprotection pathway have long been reported in vitro. During starvation, cultured male neurons readily undergo autophagy and die, whereas neurons from females mobilize fatty acids, accumulate triglycerides, form lipid droplets, and survive longer [6, 7]. However, only in few cases, the possible gender-associated differences in autophagy have been investigated in vivo and are still less in normal physiological conditions [7–9]. Recent studies have also shown not only a sexual dimorphism in autophagy but also tissue specificity in constitutive autophagy in adult rats .
The aim of this study was to investigate the sex differences in autophagy under normal physiological conditions in spinal cord and muscle tissue from wild type mice. RNA and protein level expression of the microtubule-associated protein 1 light chain 3 (LC3) and p62/sequestosome 1 (p62) were assessed, as these are the most commonly used markers to monitor autophagy. LC3 is associated with completed autophagosome, while p62 becomes incorporated into the completed autophagosome through its direct binding to LC3 and is subsequently degraded in the autolysosomes [9, 10].
2. Material and Methods
From each sex, twelve wild type mice (B6SJL) at postnatal (P) days 40, 60, 90, and 120 were used in the study. These selected ages corresponded to the progression of the sexual maturation of the animals and therefore this study could be carried out to follow accurately this progression. The Ethic Committee for Animal Experiments of the University of Zaragoza approved all experimental procedures. Animal care and experimentation were performed accordingly with the Spanish Policy for Animal Protection RD53/2013, which meets the European Union Directive 2010/63/UE on the protection of animals used for experimental and other scientific purposes. Food and water were available ad libitum. The mice were sacrificed by CO2 anaesthesia. Spinal cord and skeletal muscle were dissected, snap-frozen, and preserved at −80°C.
For RNA extraction, spinal cord and skeletal muscle tissue were pulverized in liquid nitrogen with a cell crusher using Trizol Reagent (Invitrogen). RNA was treated with Turbo DNA-free kit (Ambion) to eliminate genomic DNA. Reverse transcription was carried out according to the SuperScript First-Strand Synthesis System kit (Invitrogen). Gene expression was assayed by real-time PCR. Primer and probe mixture for LC-3 (Map1lc3a, Mm00458724_m1) and p62 (Sqstm1, Mm00448091_m1) were supplied by Applied Biosystems. Two endogenous genes (GAPDH: 4352932E and β-actin: 4352933E, Applied Biosystems) were used for normalization of the data . Target gene expression was normalized using the geometric mean of these two housekeeping genes and relative gene expression was determined using the method [12, 13]. All reactions were performed in triplicate and the primer/probe efficiencies of sets were close to 100%.
2.3. Western Blot
Powdered tissue was homogenized in RIPA lyses buffer with protease inhibitors (Complete, Roche); the homogenate was centrifuged at 10000 g for 10 min at 4°C and the resulting supernatants were collected. Protein concentration was determined by BCA method (Sigma-Aldrich). Forty micrograms of total protein was subjected to SDS/PAGE and transferred to PVDF membranes (Amersham Biosciences). Membranes were incubated in blocking solution overnight at 4°C and then incubated one hour with primary antibodies against LC-3 (1:1000, MBL), p62/SQSTM1 (1:1000, Enzo Life Sciences), and GAPDH (1:1000, Santa Cruz). After incubation with HRP-conjugated secondary antibodies (Santa Cruz), bands were visualized by enhanced chemiluminescent reagent (GE Healthcare Life Science). Immunoblots were exposed and scanned and densitometry was measured with AlphaEaseFC software (Bonsai).
2.4. Statistical Analysis
Different groups were compared using Student’s t-test. This statistical analysis was carried out in SPSS version 19.0 software (IBM). The data are presented as means, and error bars represent the standard error of the mean (SEM). Significance was set at a value of less than 0.05.
3.1. RT-PCR in Muscle and Spinal Cord Tissue
At the transcriptional level in spinal cord tissue (Figure 1(a)), LC3 expression levels were generally lower in females than in males, and statistical differences were found at P60, P90, and P120 (*). p62 mRNA expression levels in females were lower than in males at all studied ages (*). Notably, the expression of both genes maintained constant proportional levels between the sexes at all different ages. In skeletal muscle tissue (Figure 1(b)), the mRNA expression pattern was similar to the one observed in spinal cord. In the case of LC-3 transcripts, females showed less LC-3 expression levels than males. The differences between the sexes were significant at each studied age, although the most significant difference was detected at P90 (***) and P60 (**). Also, the p62 gene expression was significantly decreased in females at all ages, and the most significant difference between sexes was at P40 (***) and P90 (**).
3.2. Western Blot in Spinal Cord Tissue
The immunoblot analysis of spinal cord extracts revealed that LC3-II and p62 protein levels in females increased until P60 and later decreased gradually until P120 (Figure 2). In males, the LC3-II highest expression levels were reached at P60 and the most significant differences between males and females were detected at this age (***). At P40 and P90, LC3-II expression levels were significantly lower in females (*). Moreover, at P60, LC3-II, and p62 protein levels in females reached the maximum levels and significant differences between males and females were detected (*** and *, resp.). The males showed the highest expression levels of p62 at P90 and, in case of p62 protein, the males even doubled the expression levels of females (***).
3.3. Western Blot in Skeletal Muscle Tissue
Interestingly, LC3 western blot analysis of skeletal muscle tissue revealed two bands corresponding to LC3-I and the activated form, LC3-II (18 and 16 kDa, resp.) (Figure 3). The expression of LC3-II in males increased until P90, although it was similar along the studied ages. In females, the highest LC3-II expression was at P40 and significant differences between males and females were detected at P40 and P60 (*** and *, resp.). LC3-I was not detectable in all the replicate samples and its expression was quite variable. At P60 and P120, females showed lower LC3-I levels than males (* and ***, resp.). The expression of p62 was not affected by sex at P40, P60, and P120. However, at P90, females showed higher expression levels than males (*).
Experimental studies have demonstrated sex-dependent physiological, morphological, and hormonal differences, and therefore the capability of biological response can be different in both sexes . A number of studies have confirmed sexual dimorphism under pathological and various physiological conditions, underlining the need to include both sexes in the experimental groups. The inclusion of female sex in basic research and clinical trials, such as drug trials, has been essential to reveal potentially different responses and minimize the possibility of adverse sex-dependent effects .
This issue was particularly relevant in the case of diseases, in which gender had already been shown to modify the associated pathology, the age of onset, disease progression, or the efficiency of the treatment . Many diseases have been associated with alterations in autophagy and consequently some gender-associated differences have already been demonstrated . For instance, in neurodegenerative disorders, estrogen was neuroprotective and enhanced neurotrophic/synaptic plasticity . In vascular biology, compelling data indicated that sex differences were not only determined by sex steroid levels but may also be modified by innate cellular differences between males and females .
Regarding autophagy, only few studies allow for the possible influence of sex-dependence in this molecular process. One of the studies proposed the autophagy as a survival mechanism in males, whereas in female’s autophagy resulted in detachment-derived cell death . In accordance with these studies, it has been reported recently that sex differences in constitutive autophagy was found in rats and, moreover, this sexual dimorphism was organ specific . Furthermore, in vitro studies also showed a sexual dimorphism in autophagic processes in cancer [12, 13] and in neurons under starvation .
Taking into consideration these reported findings, in the present study, differences in constitutive autophagy between males and females of wild type mice are shown. Since the selected ages of the animals in this study have been accurately studied to follow their maturation progress in physiological conditions, in which no influence of disease takes place, the different features displayed by both sexes in this study could be mainly due to hormonal regulators, as previously suggested by Maselli et al. . Significant differences of LC-3 and p62 transcriptional expression levels in spinal cord and skeletal muscle tissues during sexual maturation of the animals have been observed. Furthermore, these differences appeared also at protein levels, in particular at P60 and P90 in spinal cord, in which sexual maturation was completed and at the early stages of maturation process in skeletal muscle. Moreover a different pattern of expression in spinal cord and muscle and, only in the case of muscle tissue, LC3-I protein levels (inactive form of LC3) were detected. Accordingly with previous studies , this result suggested a tissue-dependent modulation mechanism of autophagy under physiological conditions.
We conclude that sex and tissue specific differences exist in physiological autophagy from juvenile to young mice. Therefore, a better knowledge of the wild type mice profile pattern is needed to guarantee a correct interpretation of the results. These results have special importance as they suggest that the sex must be taken into account in the experimental design in order to minimize potential adverse consequences of sex bias.
Conflict of Interests
The authors declare that they have no conflict of interests.
The authors would like to thank Silvia Garcés, Pilar Lierta, and Miriam de la Torre for their expert technical assistance. They also thank Dr. Patricia Boya for her helpful assistance. This work was supported by Grants PI10/0178 from Fondo de Investigación Sanitaria of Spain, no. 554406 from ALS Association, and INNPACTO IPT-2011-1091-900000 Ministerio de Ciencia e Innovación.
- A. K. Beery and I. Zucker, “Sex bias in neuroscience and biomedical research,” Neuroscience and Biobehavioral Reviews, vol. 35, no. 3, pp. 565–572, 2011.
- N. Mizushima and M. Komatsu, “Autophagy: renovation of cells and tissues,” Cell, vol. 147, no. 4, pp. 728–741, 2011.
- M. Komatsu, S. Waguri, T. Chiba et al., “Loss of autophagy in the central nervous system causes neurodegeneration in mice,” Nature, vol. 441, no. 7095, pp. 880–884, 2006.
- T. Hara, K. Nakamura, M. Matsui et al., “Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice,” Nature, vol. 441, no. 7095, pp. 885–889, 2006.
- M. Komatsu, T. Ueno, S. Waguri, Y. Uchiyama, E. Kominami, and K. Tanaka, “Constitutive autophagy: vital role in clearance of unfavorable proteins in neurons,” Cell Death and Differentiation, vol. 14, no. 5, pp. 887–894, 2007.
- L. Du, R. W. Hickey, H. Bayir et al., “Starving neurons show sex difference in autophagy,” The Journal of Biological Chemistry, vol. 284, no. 4, pp. 2383–2396, 2009.
- E. Straface, L. Gambardella, M. Brandani, and W. Malorni, “Sex differences at cellular level: ‘cells have a sex’,” in Sex and Gender Differences in Pharmacology, vol. 214 of Handbook of Experimental Pharmacology, pp. 49–65, Springer, Berlin, Germany, 2012.
- I. Vega-Naredo and A. Coto-Montes, “Physiological autophagy in the Syrian hamster Harderian gland,” Methods in Enzymology, vol. 451, pp. 457–476, 2009.
- I. Campesi, E. Straface, S. Occhioni, A. Montella, and F. Franconi, “Protein oxidation seems to be linked to constitutive autophagy: a sex study,” Life Sciences, vol. 93, no. 4, pp. 145–152, 2013.
- N. Mizushima, T. Yoshimori, and B. Levine, “Methods in mammalian autophagy research,” Cell, vol. 140, no. 3, pp. 313–326, 2010.
- I. Vega-Naredo, B. Caballero, V. Sierra et al., “Sexual dimorphism of autophagy in Syrian hamster Harderian gland culminates in a holocrine secretion in female glands,” Autophagy, vol. 5, no. 7, pp. 1004–1017, 2009.
- S. John, I. Nayvelt, H.-C. Hsu et al., “Regulation of estrogenic effects by beclin 1 in breast cancer cells,” Cancer Research, vol. 68, no. 19, pp. 7855–7863, 2008.
- P. F. Cosper and L. A. Leinwand, “Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner,” Cancer Research, vol. 71, no. 5, pp. 1710–1720, 2011.
- J. L. Johnson, L. Greaves, and R. Repta, “Better science with sex and gender: facilitating the use of a sex and gender-based analysis in health research,” International Journal for Equity in Health, vol. 8, article 14, 2009.
- E. Check Hayden, “Sex bias blights drug studies,” Nature, vol. 464, no. 7287, pp. 332–333, 2010.
- P. Lista, E. Straface, S. Brunelleschi, F. Franconi, and W. Malorni, “On the role of autophagy in human diseases: a gender perspective,” Journal of Cellular and Molecular Medicine, vol. 15, no. 7, pp. 1443–1457, 2011.
- D. W. Brann, K. Dhandapani, C. Wakade, V. B. Mahesh, and M. M. Khan, “Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications,” Steroids, vol. 72, no. 5, pp. 381–405, 2007.
- C. Vitale, M. E. Mendelsohn, and G. M. C. Rosano, “Gender differences in the cardiovascular effect of sex hormones,” Nature Reviews. Cardiology, vol. 6, no. 8, pp. 532–542, 2009.
- A. Maselli, P. Matarrese, E. Straface, S. Canu, F. Franconi, and W. Malorni, “Cell sex: a new look at cell fate studies,” The FASEB Journal, vol. 23, no. 4, pp. 978–984, 2009.